$40.00
-0.2-0.50%
Pre-Market: 6:12 PM EDT
15 minutes delayed
Comments
Loading...
Mirum Pharmaceuticals
MIRMNASDAQ
Mirum Pharmaceuticals (NASDAQ:MIRM) Stock, Insider Trading Activity
Mirum Pharmaceuticals: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Mirum Pharmaceuticals Inc Insiders Doing?
At Mirum Pharmaceuticals Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of - shares worth -, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Mirum Pharmaceuticals Inc
Institutional Shares Held
22.958M
Institutional Percentage Held
48.7%
| Jul 03, 2024 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 667.00 | $34.00 | -$12.75K | SELL-OPTIONS | 37.92% | 2.43K | Jul 01 - Jul 02 | View |
| Jun 25, 2024 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.47 | -$949.28K | SELL-OPTIONS | 0.00% | 102.41K | Jun 24 | View |
| Jun 07, 2024 | Saira Ramasastry | — | 0.00 | $19.90 | -$57.80K | SELL-OPTIONS | 0.00% | 0.00 | Jun 05 | View |
| Mar 27, 2024 | ERIC BJERKHOLT | CHIEF FINANCIAL OFFICER | 2.00K | $24.80 | $49.60K | BUY | 16.67% | 14.00K | Mar 27 | View |
| Mar 25, 2024 | Peter Radovich | PRESIDENT AND COO | -4.30K | $25.80 | -$111.02K | SELL | -12.92% | 29.01K | Mar 25 | View |
| Mar 18, 2024 | Peter Radovich | PRESIDENT AND COO | -1.38K | $20.62 | -$28.44K | SELL | -3.97% | 33.32K | Jan 09 | View |
| Mar 18, 2024 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | -1.38K | $20.62 | -$28.44K | SELL | -1.33% | 102.31K | Jan 09 | View |
| Mar 18, 2024 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -38.00 | $15.63 | -$10.42K | SELL | -0.04% | 104.37K | Sep 10 - Jan 09 | View |
| Mar 18, 2024 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | -5.16K | $20.62 | -$106.39K | SELL | -1.69% | 300.52K | Jan 09 | View |
| Mar 18, 2024 | ERIC BJERKHOLT | CHIEF FINANCIAL OFFICER | 2.00K | $25.80 | $51.60K | BUY | 20.00% | 12.00K | Mar 18 | View |
| Feb 05, 2024 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | -1.21K | $26.19 | -$31.80K | SELL | -1.16% | 103.69K | Feb 02 | View |
| Feb 05, 2024 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -847.00 | $26.19 | -$22.18K | SELL | -0.80% | 104.41K | Feb 02 | View |
| Feb 05, 2024 | Peter Radovich | PRESIDENT AND COO | -1.79K | $26.19 | -$46.88K | SELL | -4.91% | 34.70K | Feb 02 | View |
| Feb 05, 2024 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | -6.01K | $26.19 | -$157.49K | SELL | -1.93% | 305.68K | Feb 02 | View |
| Feb 02, 2024 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 1.04K | $26.19 | -$19.25K | SELL-OPTIONS | 143.63% | 1.76K | Jan 31 - Feb 02 | View |
| Jan 09, 2024 | Peter Radovich | CHIEF OPERATING OFFICER | -1.41K | $28.03 | -$39.47K | SELL | -3.72% | 36.48K | Jan 08 | View |
| Jan 09, 2024 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -1.02K | $28.04 | -$28.57K | SELL | -0.96% | 105.25K | Jan 08 | View |
| Jan 09, 2024 | Pamela Vig | HEAD OF RESEARCH & DEVELOPMENT | -1.41K | $28.03 | -$39.47K | SELL | -1.32% | 104.91K | Jan 08 | View |
| Jan 09, 2024 | Christopher Peetz | PRESIDENT AND CEO | -5.21K | $28.03 | -$146.03K | SELL | -1.64% | 311.69K | Jan 08 | View |
| Jan 09, 2024 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 722.00 | $28.04 | -$14.80K | SELL-OPTIONS | ∞ | 722.00 | Jan 06 - Jan 08 | View |
| Dec 06, 2023 | Jody Howe | SVP, GLOBAL CONTROLLER | 0.00 | $17.67 | -$73.65K | SELL-OPTIONS | 0.00% | 0.00 | Dec 05 | View |
| Nov 14, 2023 | Patrick Heron | DIRECTOR | 2.91K | $28.30 | $82.35K | BUY | 0.08% | 3.73M | Nov 09 | View |
| Sep 15, 2023 | Patrick Heron | DIRECTOR | 2.63K | $31.02 | $81.42K | BUY | 0.07% | 3.73M | Sep 13 | View |
| Sep 14, 2023 | MICHAEL GREY | DIRECTOR | 0.00 | $17.47 | -$424.57K | SELL-OPTIONS | 0.00% | 93.75K | Sep 13 - Sep 14 | View |
| Sep 13, 2023 | Patrick Heron | DIRECTOR | 8.44K | $30.44 | $256.79K | BUY | 0.23% | 3.72M | Sep 11 - Sep 12 | View |
| Sep 12, 2023 | ERIC BJERKHOLT | CHIEF FINANCIAL OFFICER | 10.00K | $29.65 | $296.49K | BUY | ∞ | 10.00K | Sep 11 | View |
| Sep 05, 2023 | Patrick Heron | DIRECTOR | 147.99K | $26.25 | $3.88M | BUY | 4.15% | 3.71M | Aug 31 | View |
| Aug 28, 2023 | Jody Howe | SVP, GLOBAL CONTROLLER | -3.46K | $26.23 | -$90.74K | SELL | -100.00% | 0.00 | Aug 25 | View |
| Jul 05, 2023 | Peter Radovich | CHIEF OPERATING OFFICER | -1.43K | $25.65 | -$36.55K | SELL | -3.64% | 37.67K | Jul 03 | View |
| Jul 05, 2023 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -1.00K | $25.65 | -$25.75K | SELL | -0.94% | 105.84K | Jul 03 | View |
| Jul 05, 2023 | Pamela Vig | HEAD RESEARCH & DEVELOPMENT | -1.43K | $25.65 | -$36.55K | SELL | -1.33% | 105.79K | Jul 03 | View |
| Jul 05, 2023 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 1.69K | $25.65 | -$23.47K | SELL-OPTIONS | 95.53% | 3.46K | Jun 30 - Jul 03 | View |
| Jul 05, 2023 | Christopher Peetz | PRESIDENT AND CEO | -5.50K | $25.65 | -$141.01K | SELL | -1.71% | 316.90K | Jul 03 | View |
| Jun 09, 2023 | MICHAEL GREY | DIRECTOR | 0.00 | $15.97 | -$380.74K | SELL-OPTIONS | 0.00% | 93.75K | Jun 08 | View |
| May 04, 2023 | MICHAEL GREY | DIRECTOR | 0.00 | $15.47 | -$366.13K | SELL-OPTIONS | 0.00% | 93.75K | May 03 | View |
| Nov 15, 2022 | Niall O'Donnell Attorney-in-Fact | DIRECTOR | -300.00K | $19.86 | -$5.96M | SELL | -15.62% | 1.62M | Nov 11 - Nov 15 | View |
| Jun 08, 2022 | James FlynnDeerfield Mgmt HIF LPDeerfield Mgmt IV LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Private Design Fund IV LPDeerfield Healthcare Innovations Fund LP | 10% OWNER | -38.48K | $25.01 | -$962.26K | SELL | -2.44% | 1.54M | Jun 06 | View |
| Nov 29, 2021 | Ian Clements | CHIEF FINANCIAL OFFICER | 1.45K | $14.14 | $20.50K | BUY | 8.47% | 18.56K | Nov 24 - Nov 26 | View |
| Nov 29, 2021 | Christopher Peetz | PRESIDENT AND CEO | 7.00K | $14.40 | $100.80K | BUY | 3.14% | 229.60K | Nov 24 | View |
| Oct 01, 2021 | Christopher Peetz | PRESIDENT AND CEO | 18.20K | $19.26 | -$70.71K | GRANT | 8.91% | 222.60K | Sep 29 - Oct 01 | View |
| Oct 01, 2021 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | 6.76K | $19.26 | -$26.26K | GRANT | 8.68% | 84.67K | Sep 29 - Oct 01 | View |
| Oct 01, 2021 | Ian Clements | CHIEF FINANCIAL OFFICER | 7.80K | $19.26 | -$30.31K | GRANT | 88.13% | 16.65K | Sep 29 - Oct 01 | View |
| Oct 01, 2021 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | 7.16K | $19.26 | -$18.51K | GRANT | 9.29% | 84.25K | Sep 29 - Oct 01 | View |
| Oct 01, 2021 | Peter Radovich | CHIEF OPERATING OFFICER | 6.76K | $19.26 | -$26.26K | GRANT | 149.84% | 11.27K | Sep 29 - Oct 01 | View |
| Oct 01, 2021 | Jonathan Edwin Tucker | CHIEF MEDICAL OFFICER | 6.76K | $19.26 | -$26.26K | GRANT | 17.33% | 45.77K | Sep 29 - Oct 01 | View |
| Jul 13, 2021 | James FlynnDeerfield Mgmt HIF LPDeerfield Mgmt IV LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Private Design Fund IV LPDeerfield Healthcare Innovations Fund LPDeerfield Mgmt LPDeerfield Special Situations Fund LP | 10% OWNER | -99.33K | $15.81 | -$1.57M | SELL | -5.45% | 1.72M | Jul 09 | View |
| Jul 07, 2021 | James FlynnDeerfield Mgmt HIF LPDeerfield Mgmt IV LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Private Design Fund IV LPDeerfield Healthcare Innovations Fund LPDeerfield Mgmt LPDeerfield Special Situations Fund LP | 10% OWNER | -66.67K | $16.29 | -$1.09M | SELL | -3.53% | 1.82M | Jul 02 - Jul 07 | View |
| Dec 28, 2020 | Ian Clements | — | 2.47K | $18.61 | $45.97K | PURCHASE | 45.99% | 7.84K | Dec 23 | View |
| Dec 28, 2020 | Christopher Peetz | — | 5.00K | $18.70 | $93.48K | PURCHASE | 2.53% | 202.94K | Dec 23 | View |
| Mar 23, 2020 | Jonathan Edwin Tucker | — | 4.50K | $11.01 | $49.56K | PURCHASE | 300.00% | 6.00K | Mar 19 - Mar 20 | View |
| Sep 18, 2019 | Laurent Fischer | DIRECTOR | 2.10K | $9.39 | $19.72K | BUY | 45.16% | 6.75K | Sep 16 - Sep 17 | View |
| Sep 12, 2019 | Laura Brege | DIRECTOR | 10.00K | $11.22 | $112.20K | BUY | ∞ | 10.00K | Sep 10 | View |
| Sep 10, 2019 | Ian Clements | SVP FINANCE & COMMUNICATIONS | 4.00K | $11.51 | $46.04K | BUY | ∞ | 4.00K | Sep 06 | View |
| Sep 10, 2019 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | 1.61K | $10.97 | $17.68K | BUY | 2.15% | 76.61K | Sep 06 | View |
| Sep 10, 2019 | Christopher Peetz | PRESIDENT AND CEO | 9.07K | $11.02 | $99.94K | BUY | 4.84% | 196.57K | Sep 06 - Sep 09 | View |
| Sep 10, 2019 | Laurent Fischer | DIRECTOR | 4.65K | $10.60 | $49.30K | BUY | ∞ | 4.65K | Sep 06 - Sep 10 | View |
| Jul 24, 2019 | Edward Paul Walker | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | Peter Sonsini | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | SCOTT SANDELL | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | DAVID MOTT | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | JOSHUA MAKOWER | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | Mohamad Makhzoumi | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | Anthony Florence Jr | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | Carmen Chang | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | Ali Behbahani | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | FOREST BASKETT | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | PETER BARRIS | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | New Enterprise Associates LPNEA Partners LPNEA GP LLC | 10% OWNER | 4.19M | $15.00 | $6.75M | BUY | ∞ | 4.19M | Jul 22 | View |
| Jul 24, 2019 | Frazier Life Sciences IX LPFHMLS IX LPFHMLS IX LLCJames Topper | 10% OWNER | 3.57M | $15.00 | $6.75M | BUY | ∞ | 3.57M | Jul 22 | View |
| Jul 24, 2019 | Niall ODonnell | DIRECTOR | 1.80M | $15.00 | $4.50M | BUY | 1436.89% | 1.92M | Jul 22 | View |
| Jul 24, 2019 | Patrick Heron | DIRECTOR | 3.57M | $15.00 | $6.75M | BUY | ∞ | 3.57M | Jul 22 | View |
| Jul 24, 2019 | James FlynnDeerfield Mgmt HIF LPDeerfield Mgmt IV LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Private Design Fund IV LPDeerfield Healthcare Innovations Fund LPDeerfield Mgmt LPDeerfield Special Situations Fund LP | 10% OWNER | 3.45M | $15.00 | $4.98M | BUY | ∞ | 166.00K | Jul 22 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.